Impact of High-Performance Expansion and Shrinkage-Reducing Agents on the Mechanical Properties and Shrinkage Compensation of High-Strength Concrete
Autor(en): |
Yun-Feng Xi
Jin Lee Bao-Ling Chen Bing Yang Miao-Zhang Yu Xiao-Zhou Yan Li Zhu |
---|---|
Medium: | Fachartikel |
Sprache(n): | Englisch |
Veröffentlicht in: | Buildings, 26 Februar 2023, n. 3, v. 13 |
Seite(n): | 717 |
DOI: | 10.3390/buildings13030717 |
Abstrakt: |
A large number of binder ingredients such as cement and active mineral admixtures are used in the preparation of high-strength concrete, and the water:binder ratio is extremely low. This leads to a large amount of shrinkage of concrete at the early stage of curing, which poses a great threat to the safety and durability of the structure. To solve the cracking problem of high-strength concrete induced by high shrinkage, we choose to change the admixture to solve it. In this study, a high-performance expansion agent (HPEA) and shrinkage-reducing agent, which are currently studied in a small number, were selected by changing the way of admixture, and their effects on the strength and shrinkage of high-strength concrete were compared and analyzed. The results show that the addition of a HPEA is beneficial to the compressive strength of concrete and sufficient expansion can be obtained by using a high amount of HPEA, but there is an excessive and delayed expansion to produce cracks in the later stage. A shrinkage-reducing agent plays an adverse role in the development of concrete strength, but it performs better in inhibiting shrinkage. The combination of a HPEA and shrinkage reducing agent can largely avoid the formation of cracks, and the two have a certain synergy. The main reason is that a HPEA compensates for some of the negative effects of a shrinkage-reducing agent on concrete strength, and the shrinkage-reducing agent further strengthens the inhibition effect of a HPEA on concrete shrinkage, and to some extent avoids the risk of cracks caused by delayed expansion caused by admixture problems. |
Copyright: | © 2023 by the authors; licensee MDPI, Basel, Switzerland. |
Lizenz: | Dieses Werk wurde unter der Creative-Commons-Lizenz Namensnennung 4.0 International (CC-BY 4.0) veröffentlicht und darf unter den Lizenzbedinungen vervielfältigt, verbreitet, öffentlich zugänglich gemacht, sowie abgewandelt und bearbeitet werden. Dabei muss der Urheber bzw. Rechteinhaber genannt und die Lizenzbedingungen eingehalten werden. |
3.4 MB
- Über diese
Datenseite - Reference-ID
10712349 - Veröffentlicht am:
21.03.2023 - Geändert am:
10.05.2023